Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 22, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.2K

Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.

Olivia M Dong1,2, Jill Bates1,3, Catherine Chanfreau-Coffinier4

  • 1Durham VA Health Care System, Durham, NC 27705, USA.

Pharmacogenomics
|January 6, 2021
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Physical Activity on Clinical Outcomes in Veterans Completing the VA's Traumatic Brain Injury Screening and Evaluation Program.

The Journal of head trauma rehabilitation·2026
Same author

Mid- and late-life depression increases risk of Alzheimer's disease and related dementias in veterans.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Examining the additive risk of TBI and comorbid conditions on dementia in military veterans: a retrospective cohort study.

Alzheimer's research & therapy·2026
Same author

Traumatic Brain Injury and High Combat Exposure Pose Additive Risk for Specific Chronic Health Conditions in Veterans Affairs Million Veteran Program Enrollees.

Journal of neurotrauma·2026
Same author

Transforming the Patient-Centered Medical Home: Reimagining Primary Care Through AI.

Journal of general internal medicine·2026
Same author

Germline polygenic score for prostate cancer aggressiveness.

medRxiv : the preprint server for health sciences·2026
Summary

The Veterans Affairs (VA) launched the Pharmacogenomic Testing for Veterans (PHASER) program, offering multi-gene pharmacogenomic (PGx) testing to 250,000 veterans. This initiative aims to optimize drug response through large-scale PGx implementation across multiple sites.

Area of Science:

  • Pharmacogenomics
  • Clinical Implementation
  • Healthcare Systems

Background:

  • The Veterans Affairs (VA) initiated the Pharmacogenomic Testing for Veterans (PHASER) program in 2019, a large-scale clinical program providing multi-gene pharmacogenomic (PGx) testing.
  • The program targets up to 250,000 veterans across approximately 50 sites, with a phased rollout over five years (2019-2023) to enable iterative quality improvements.

Discussion:

  • The PHASER program addresses a gap in current resources by focusing on the multisite, remote implementation of panel-based PGx testing.
  • Iterative program improvements are facilitated through Plan-Do-Study-Act cycles during the staggered site initiation.
  • The program aims to develop a roadmap for maximizing the uptake and optimizing the use of PGx testing.

Key Insights:

  • Large-scale implementation of pharmacogenomic testing within a major integrated healthcare system.
Keywords:
Veterans Affairsclinical programpharmacogeneticspharmacogenomicsprecision medicineveterans

More Related Videos

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice
06:00

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice

Published on: May 24, 2024

1.2K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.8K

Related Experiment Videos

Last Updated: Nov 22, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.2K
Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice
06:00

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice

Published on: May 24, 2024

1.2K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.8K
  • Phased rollout strategy supports iterative quality improvement and adaptation.
  • Focus on multisite, remote implementation challenges and solutions for PGx testing.
  • Outlook:

    • The PHASER program is expected to provide a scalable model for integrating PGx testing into routine clinical practice.
    • Development of best practices for maximizing PGx test utilization to enhance patient outcomes.
    • Potential to significantly improve drug response and reduce adverse events for a large veteran population.